Explain this page
Arphra AIPlain-English read on KLA Corporation’s valuationIncome statement
| In USD | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | 2026E | 2027E | 2028E | 2029E |
|---|---|---|---|---|---|---|---|---|---|
| Revenue & profit | |||||||||
| Revenue | $6.92B | $9.21B | $10.5B | $9.81B | $12.16B | $13.52B | $17.09B | $19.5B | $21.1B |
| Cost of revenue | $2.77B | $3.59B | $4.22B | $3.93B | $4.58B | $5.23B | $6.65B | $7.46B | $8.04B |
| Gross profit | $4.15B | $5.62B | $6.28B | $5.88B | $7.58B | $8.4B | $10.32B | $12.13B | $13.07B |
| Gross margin | +59.93% | +61.00% | +59.81% | +59.97% | +62.32% | +62.14% | +60.41% | +62.19% | +61.97% |
| Operating | |||||||||
| Research & development | $928.49M | $1.11B | $1.3B | $1.28B | $1.36B | $1.68B | $2.08B | $2.44B | $2.54B |
| Selling, general & administrative | $729.6M | $860.01M | $986.33M | $969.51M | $979.02M | $1.22B | $1.52B | $1.8B | $1.89B |
| Total operating expenses | $1.66B | $1.97B | $2.28B | $2.25B | $2.33B | $2.82B | $3.66B | $4.08B | $4.47B |
| Operating income | $2.49B | $3.65B | $3.99B | $3.64B | $5.24B | $5.44B | $6.61B | $7.48B | $8.25B |
| Operating margin | +35.97% | +39.67% | +38.06% | +37.05% | +43.11% | +40.23% | +38.67% | +38.38% | +39.10% |
| EBITDA | $2.85B | $4.01B | $4.5B | $3.9B | $5.34B | $5.6B | $7.28B | $8.07B | $8.96B |
| EBIT | $2.52B | $3.65B | $4.09B | $3.5B | $4.95B | $5.14B | $6.51B | $7.39B | $8.04B |
| Below the line | |||||||||
| Interest expense | $157.33M | $160.34M | $296.94M | $311.25M | $302.17M | $391.69M | $494.98M | $549.21M | $581.25M |
| Interest income | $8.93M | $8.7M | $74.1M | $160.69M | $180.28M | $168.17M | $222.94M | $245.75M | $267.19M |
| Other income / expense | -$128.03M | -$164.94M | -$205.51M | -$445.65M | -$596.6M | — | — | — | — |
| Pre-tax income | $2.36B | $3.49B | $3.79B | $3.19B | $4.64B | $4.83B | $6.11B | $6.76B | $7.32B |
| Income tax expense | $283.1M | $167.18M | $401.84M | $428.14M | $582.81M | $574.46M | $745.59M | $857.32M | $908.68M |
| Earnings | |||||||||
| Net income | $2.08B | $3.32B | $3.39B | $2.76B | $4.06B | $4.35B | $5.19B | $6.12B | $6.75B |
| Net income · continuing ops | $2.08B | $3.32B | $3.39B | $2.76B | $4.06B | $4.13B | $5.41B | $6.22B | $6.61B |
| Net margin | +30.04% | +36.06% | +32.27% | +28.15% | +33.41% | +32.17% | +30.34% | +31.39% | +31.97% |
| EPS · basic | $13.49 | $22.07 | $24.28 | $20.41 | $30.53 | $36.71 | $50.42 | $60.40 | $65.90 |
| EPS · diluted | $13.37 | $21.92 | $24.15 | $20.28 | $30.37 | $37.04 | $50.25 | $60.23 | $64.75 |
| EPS · low estimate | — | — | — | — | — | $36.88 | $47.34 | $51.57 | $59.83 |
| EPS · high estimate | — | — | — | — | — | $37.52 | $52.84 | $78.45 | $68.45 |
| Shares · basic | 154.09M | 150.49M | 139.48M | 135.35M | 133.03M | 133.86M | 133.84M | 132.21M | 132.19M |
| Shares · diluted | 155.44M | 151.56M | 140.24M | 136.19M | 133.75M | 132.8M | 133.38M | 134.12M | 134.68M |
| Coverage | |||||||||
| Analysts (revenue) | — | — | — | — | — | 21 | 20 | 16 | 8 |
| Analysts (EPS) | — | — | — | — | — | 17 | 17 | 8 | 5 |
Coverage notes. Historical figures come’s as-reported income statements / balance sheets / cash flows in our data warehouse. Forecast columns (italicised, faint accent tint) carry vendor-supplied numbers where available (revenue + EPS consensus) and ratio-derived values for every other line. Margins / ratios are the trailing-3y average from history applied to the forecast revenue; values are clamped to enforce P&L identity (gross ≥ operating, EBITDA ≥ operating, net ≤ operating) and balance-sheet identity (assets = liabilities + equity by construction). Cash-flow FCF reconciles to OCF + CapEx. USD conversion uses the period-end close of the issuer's reported/USD pair from forex_prices_daily; share counts stay unconverted.
Financials
Full income statement, balance sheet, and cash-flow history is included with Pro.
Upgrade to Pro